Asset Manager

PRICE T ROWE ASSOCIATES INC /MD/

Baltimore, MD SEC Registered Investment Advisor Institutional CIK: 0000080255
13F Score ?
20
3Y · Top 10 · Mgr Wt
13F Score ?
26
7Y · Top 10 · Mgr Wt
S&P 500 ?
80
Benchmark
$927M
AUM
-6.72%
2025 Q4
+6.13%
1-Year Return
+37.47%
Top 10 Concentration
+8.91%
Turnover
-0.78%
AUM Change
Since 1999
First Filing
3043
# of Holdings

Fund Overview

13F Filed: 2026-02-17

As of 2025 Q4, Price T Rowe Associates Inc /md/ manages $927M in reported 13F assets , holds 3043 positions with +37.47% top-10 concentration , and delivered a 1-year return of +6.13% on its disclosed equity portfolio. Filing 13F reports since 1999.

About

Investment Strategy

Analytics Summary

Risk Profile

Key Personnel

Rob Sharps — President & Chief Executive Officer
Jen Dardis — Chief Financial Officer
Eric Veiel — Head of Global Investments & Chief Investment Officer
Official 13F Filings — SEC EDGAR Key personnel and Fund Overview may contain mistakes

Activity Summary — 2025 Q4

Q4 2025 13F Filed: Feb 17, 2026

Top Buys

% $
Stock % Impact
+0.62%
+0.59%
+0.49%
+0.24%
+0.21%
KLAC KLA CORP..
+0.18%

Top Sells

% $
Stock % Impact
-0.83%
-0.56%
-0.55%
-0.46%
-0.24%
-0.20%

Top Holdings

2025 Q4
Stock %
7.50%
6.56%
5.97%
3.26%
3.19%
2.83%
View All Holdings

Activity Summary

Latest
Market Value $927M
AUM Change -0.78%
New Positions 123
Increased Positions 1843
Closed Positions 77
Top 10 Concentration +37.47%
Portfolio Turnover +8.91%
Alt Turnover +9.30%

Sector Allocation Trends

Quarterly History
Free View: Last 10 Quarters. Subscribe to see full history

Holdings Analysis

Size: % of Portfolio Color: Last Full-Quarter Return No data
Free: 10 quarters

Positions Dynamics

Visualizing Top 20 holdings weight history over the last 10 quarters.

Portfolio Analytics — Latest

PRICE T ROWE ASSOCIATES INC /MD/ risk dashboard covering volatility, beta, value-at-risk, drawdowns, concentration, factor tilts, benchmark comparison, and stress testing for the latest disclosed portfolio.

Risk access
Building institutional risk profile...
Guru Intelligence Hub Pro
Real-time Analytics
High-Conviction Alpha
AAPL 92.4
NVDA 88.1
MSFT 74.3
Strategy Guardian
Style Drift 0.12
Sector Rotation 0.38

Tracking institutional benchmark deviation

Scenario Lab
2008 GFC -32.4%
Covid-19 -18.1%
2022 Bear -24.7%
Unlock the full Guru Intelligence Hub
Real conviction scores for every holding  ·  Strategy Guardian alerts  ·  Live Scenario Lab stress tests
Upgrade to Pro

Best Strategy vs. Benchmarks

AI Backtest: Auto-Optimizing...
Loading AI Backtest...
Don't be Fooled by Randomness
Access Alpha, Capture Ratios, and Batting Average calibrated for this specific strategy.
UPGRADE NOW
Nassim Taleb — author of Fooled by Randomness
Returns
--
Latest Quarter
--
1-Year Return
--
Ann. Return
Risk
--
Std Deviation
--
Max Drawdown
--
Beta vs SPY
Quality
--
Sharpe
--
Sortino
--
Win Rate
--
Payoff Ratio
Edge Metrics Last 10 quarters only
--
Alpha annualized
--
Up Capture
--
Down Capture

Strategy Backtester: PRICE T ROWE ASSOCIATES INC /MD/

Replicate top holdings performance • Compare vs benchmarks • Optimize N

Find the best N! Test multiple portfolio sizes at once to discover the optimal configuration.

Risk insights! Identify periods when the fund lagged the benchmark – critical for timing entries.

⏱ Run Backtest

Liquid Glass Edition

0
Backtests Run
+127%
Avg. Return

👆 Click the button to launch tickers!

Don't Be Fooled by Randomness
Proven alpha spans cycles, not just 24 months. Unlock full history since 1999.
PRO ACCESS
Free Demo
Try the Backtester on Real Funds
Run full-history backtests on a curated 2-3 funds. See signal quality, drawdowns, and cycle behavior before you decide.
Underperformance Analysis — Top 10 Holdings vs SPY

Backtesting PRICE T ROWE ASSOCIATES INC /MD/'s top 10 holdings against SPY identified 87 underperformance periods. Worst drawdown: 2012-12 – 2013-05 (-19.9% vs SPY, 6 quarters).

Avg. lag: -4.3% vs SPY Avg. duration: 1.9 quarters
Backtest Snapshot — Top 10 Holdings (Mn-Weighted)

The ticker-level breakdown shows how each of PRICE T ROWE ASSOCIATES INC /MD/'s top holdings contributed to portfolio returns quarter by quarter. Strongest recent contributors inside the last 5 years of the quarterly Top 10 backtest window: NVDA (2021 Q4 – 2025 Q3, +26.6 pts), MSFT (2021 Q1 – 2025 Q3, +13.6 pts), AAPL (2021 Q1 – 2025 Q3, +12.2 pts), GOOG (2021 Q1 – 2025 Q3, +5.7 pts), LLY (2022 Q3 – 2025 Q2, +5.1 pts) .

Strategy ann.: 9.7% SPY ann.: 8.3% Period: 1999–2026
Best Recent Contributors — Last 5Y
1 of 5 recent top contributors lagged SPY, which means even some of this fund's best return drivers still failed to beat a simple index over the same window.
2021 Q4 – 2025 Q3 • 15Q in Top 10 Beat SPY
NVDA
+441%
SPY
+57%
Contrib
+26.6%
2021 Q1 – 2025 Q3 • 19Q in Top 10 Lagged SPY
MSFT
+68%
SPY
+75%
Contrib
+13.6%
2021 Q1 – 2025 Q3 • 19Q in Top 10 Beat SPY
AAPL
+114%
SPY
+75%
Contrib
+12.2%
2021 Q1 – 2025 Q3 • 19Q in Top 10 Beat SPY
GOOG
+163%
SPY
+75%
Contrib
+5.7%
2022 Q3 – 2025 Q2 • 11Q in Top 10 Beat SPY
LLY
+138%
SPY
+63%
Contrib
+5.1%
Stock return (green = beat SPY)   Stock return (red = lagged SPY)   SPY same period   Cumulative contribution during the last 5 years of the quarterly Mn-weighted Top 10 strategy

Frequently Asked Questions

What does Price T Rowe Associates Inc /md/ invest in?
T. Rowe Price's investment philosophy remains rooted in the growth investing principles established by its founder, emphasizing companies with sustainable earnings growth, capable management teams, and durable competitive advantages. While the firm has expanded far beyond pure growth strategies, this fundamental orientation toward quality and long-term compounding continues to influence its investment culture. The **13F Portfolio Composition** reflects the aggregate holdings across T. Rowe Price's extensive suite of investment products, encompassing growth, value, blend, and sector-specific strategies. The **Sector Allocation History** reveals consistent emphasis on technology and healthcare—sectors aligned with the firm's growth heritage—while maintaining broad diversification across financials, consumer discretionary, industrials, and other market segments. T. Rowe Price's active management philosophy centers on fundamental, bottom-up security selection supported by proprietary global research capabilities. The firm employs over 400 investment professionals across global offices, generating differentiated insights through direct company engagement, industry analysis, and quantitative screening. This research infrastructure supports both concentrated high-conviction strategies and broadly diversified portfolio approaches. The **Top 10 Holdings Concentration** across T. Rowe Price's aggregate 13F positions reflects the firm's diversified business model rather than a single investment strategy. Individual T. Rowe Price funds may maintain significantly different concentration profiles depending on their mandates, from concentrated growth portfolios to diversified index-aware strategies.
What is Price T Rowe Associates Inc /md/'s AUM?
Price T Rowe Associates Inc /md/ reported $927M in 13F assets as of 2025 Q4. Note: 13F AUM reflects only long equity positions reported to the SEC and may differ from total assets under management.
How concentrated is Price T Rowe Associates Inc /md/'s portfolio?
Price T Rowe Associates Inc /md/ holds 3043 disclosed positions. The top 10 holdings represent +37.47% of the reported portfolio, indicating a diversified investment approach.
How to track Price T Rowe Associates Inc /md/ 13F filings?
Track Price T Rowe Associates Inc /md/'s quarterly filings on SEC EDGAR or on this page — data is updated within days of each filing deadline. Subscribe to 13Foresight for position-change alerts.
Who manages Price T Rowe Associates Inc /md/?
Price T Rowe Associates Inc /md/ is managed by Rob Sharps (President & Chief Executive Officer), Jen Dardis (Chief Financial Officer), Eric Veiel (Head of Global Investments & Chief Investment Officer).

Disclaimer: 13Foresight is not a registered investment adviser, broker-dealer, or financial planner. All information on this site is provided solely for informational and educational purposes and does not constitute investment advice, a solicitation, or a recommendation to buy or sell any security. Portfolio backtests shown on this page are hypothetical and simulated — they do not represent actual trading results and were constructed with the benefit of hindsight. Actual results would differ materially. 13F filings disclose only long equity positions valued above $10,000, submitted up to 45 days after quarter-end; they do not capture short positions, options, bonds, cash, private investments, or non-U.S. securities. A fund's backtest performance may not reflect its actual returns, as managers frequently generate alpha through strategies not visible in 13F data. Past performance is not indicative of future results. All data sourced from public SEC EDGAR filings. Use at your own risk. Full Terms of Use.

Full history →